Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hyperglycemia 2Lymphoma 1Insulin Resistance 1Hyperphagia 1Diabetes Mellitus, Type 2 1

Interventions

Insulin Glargine 2Insulin 2Alpelisib 2ziprasidone 1relacorilant 1pembrolizumab 1exemestane 1Vildagliptin 1Tamoxifen 1Olanzapine 1Metformin 1Letrozole 1Insulin Lispro 1Injections 1Fulvestrant 1DNA, Ribosomal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hyperglycemia × Insulin Glargine × Clear all
NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
15 enrolled
Lymphoid

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed
61 enrolled

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡